About This Role: As our Value & Access Sr Manager for Latin America North (LAN), you will play a pivotal role in advancing Biogen's business outcomes in Mexico and Colombia. Your efforts will focus on effectively positioning our portfolio with payers, accounts, and other key stakeholders by developing compelling value-based messages, technical tools, and strategic initiatives. You will manage the strategic direction of Biogen's value proposition across both markets, ensuring our products meet customer needs and decision drivers. This role is integral to achieving coverage and expanding market share for Biogen's offerings, fitting seamlessly within the broader business framework to enhance our influence in the healthcare landscape.
What You’ll Do:
Develop and implement pricing, health economics, and market access reimbursement strategies to fulfill LAN's objectives.
Oversee projects that support the strategic management of Biogen's value proposition in Mexico and Colombia.
Lead the creation and execution of negotiation strategies and value propositions for assigned therapeutic areas.
Assist in strategic and tactical activities related to HEOR evidence, technical dossiers, and Market Access Tools.
Design KPI frameworks and pricing strategies to support reimbursement and market access strategies.
Engage in therapeutic area coverage, including Multiple Sclerosis and Spinal Muscular Atrophy, while scouting potential for new pipeline products.
Who You Are: You are adept at navigating complex healthcare landscapes and excel at building strong relationships with stakeholders. Your bilingual proficiency in English and Spanish enhances your ability to communicate value propositions effectively. You possess a deep understanding of the Mexican healthcare system, and your experience in specialty care, particularly high-cost or rare diseases, makes you a valuable asset. Your strategic mindset and analytical prowess drive successful outcomes in market access and reimbursement.
Required Skills:
Fluent in English and Spanish.
Degree in healthcare sciences, economics, business, or similar field.
5+ years of experience in similar roles within multinational healthcare companies.
In-depth knowledge of the Mexican healthcare system; knowledge of the Colombian market is advantageous.
Expertise in health economics and outcomes research.
Experience in specialty care, particularly high-cost or rare diseases.
Proven track record in fostering relationships with senior-level stakeholders, including government and healthcare providers.
Preferred Skills:
Experience with high-cost or rare diseases in specialty care.
Familiarity with Colombian healthcare market dynamics.
Strong negotiation and strategic planning capabilities.
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Skills Required
- Fluent in English and Spanish
- Degree in healthcare sciences, economics, business, or similar field
- 5+ years of experience in similar roles within multinational healthcare companies
- In-depth knowledge of the Mexican healthcare system
- Expertise in health economics and outcomes research
- Experience in specialty care, particularly high-cost or rare diseases
- Proven track record in fostering relationships with senior-level stakeholders
Biogen Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Biogen and has not been reviewed or approved by Biogen.
-
Fair & Transparent Compensation — Pay is generally positioned as competitive and often perceived as fair across roles, with total compensation framed as strong when bonus and equity are included. Compensation sentiment is described as above-average overall, though it varies by function and business cycle.
-
Equity Value & Accessibility — Equity programs are repeatedly highlighted as a meaningful part of the total package, including stock programs and an employee stock purchase plan. Equity and bonus elements are portrayed as important contributors to feeling well rewarded beyond base pay.
-
Leave & Time Off Breadth — Time-off benefits are described as distinctive, including a year-end shutdown and a paid sabbatical after extended tenure. Vacation, holidays, sick time, and personal-significance days are also presented as supportive of work-life needs.
Biogen Insights
What We Do
Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics. With approximately 7000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Zug, Switzerland and we have world-class manufacturing facilities in North Carolina and Denmark. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries. For more information, please visit www.biogen.com. Follow us on social media – Twitter, LinkedIn, Facebook, YouTube.
